Zahrawi F et al
In addition, certain medical conditions and medications can cause vitamin B12 deficiency (30)
Whether you have a deficiency due to pernicious anemia, dietary choices like veganism, or gastrointestinal conditions such as Crohns disease, we will work closely with you to develop a personalized treatment plan
Semaglutides weight loss benefit prompted manufacturer Novo Nordisk to market semaglutide as new drug, Wegovy, with roughly twice the dosage of semaglutide as Ozempic
Typical PA requirements include: Confirmed diagnosis of type 2 diabetes or obesity Documented BMI (often 30 or 27 with comorbidities) Failed trials of other medications Lifestyle modification attempts Recent A1C lab values (for diabetes) Documentation Must Include Height and weight with calculated BMI Diagnosis supporting medical necessity Treatment plan Follow-up and monitoring plan Compliance & Audit Risk GLP-1 medications are a high-risk audit target due to: Rapid growth in utilization High drug cost Off-label prescribing Weight-loss demand Common audit issues: Incorrect diagnosis codes Missing BMI documentation Lack of medical necessity Billing weight-loss drugs to Medicare Inappropriate use of unclassified J-codes Medicare Coverage Rules Medicare Part D generally does not cover weight-loss drugs , even if FDA-approved for obesity
What to Expect, and When The Long Middle: Where the Results Actually Live The large clinical trials that established semaglutide for weight management ran for well over a year, and that duration is the single most instructive fact about this treatment
